The preproenkephalin A gene is a neurotransmitter gene whose expression can be modulated "transsynaptically" by changes in neuronal activity. DNA sequences lying within 200 base pairs of this gene's transcription start site resemble consensus binding sites for several transcription factor families. In nonneuronal cell cultures, this promoter region is sufficient to mediate gene responses to depolarization, phorbol esters, adenylate cyclase, and calcium fluxes. To assess the role that these cis-acting elements could play in preproenkephalin expression and regulation in vivo, the expression of a construct containing this 200-base-pair region fused to the chloramphenicol acetyltransferase gene was examined in transgenic mice. This promoter confers modest expression in brain, adrenal, and small intestine, with substantially higher levels in testis. These elements confer trans-synaptic regulation in two well-studied models of trans-synaptic preproenkephalin upregulation but not in a third system, underscoring the specificity of the regulatory sequence elements implicated in the synaptic regulation of neuronal genes.
The gene encoding the principal opioid peptide, preproenkephalin, displays exquisite patterns of tissue-specific and regulated expression (e.g., refs. 1-6). When brain activity changes, preproenkephalin mRNA can be "synaptically" or "trans-synaptically" regulated in regions implicated in somatosensory (5, 6) , stress (7, 8) , epileptogenic (9) (10) (11) (12) (13) (14) , reproductive/neuroendocrine (15) (16) (17) , drug administration and withdrawal (7, (18) (19) (20) , and locomotor (3, (21) (22) (23) processes.
Preproenkephalin gene promoter elements that could contribute to this regulation have been studied in cultured cells (24) (25) (26) . Responses to calcium, adenylate cyclase, and depolarization can be conferred by constructs containing a 200-base-pair 5' flanking sequence of the preproenkephalin gene; this "cassette" region incorporates sites recognizing the cyclase response element-binding protein (CREB), activator proteins 2, 4, and 1 (AP-2, AP-4, AP-1), and nuclear factor 1 (25) (26) (27) (28) (29) .
Levels of expression of several of these factors do increase with the trans-synaptic manipulations that augment preproenkephalin expression in the same brain regions. Factors that recognize AP-1 sites (Fos and Jun) increase prior to or parallel with stimulation-induced preproenkephalin upregulation in hippocampus (30) and dorsal horn (31) (32) (33) (34) in vivo.
Despite in vitro data documenting which factors are candidates for mediating trans-synaptic regulation in the brain and in vivo studies demonstrating that some of these factors are upregulated in concert with preproenkephalin, little evidence directly documents which DNA elements actually mediate gene upregulation in vivo. Transgenic animals provide an approach to understanding the molecular mechanisms that could underlie trans-synaptic regulation in vivo (for review, see ref. 35 ). Studies of mice in which specific segments of the promoter for the preproenkephalin gene are introduced stably into the genome can allow assessment of the transcriptional activity induced by the gene segment in vivo. They can provide evidence about which gene regulatory regions are necessary and sufficient to confer tissue-and cell-specific gene expression (36) and gene regulation (37) .
In vitro studies of preproenkephalin regulation have focused on pENKAT-12, a plasmid construct containing 193 base pairs of the human preproenkephalin 5' cassette-region flanking sequence, exon 1, intron 1, part of exon 2, and 1.2 kilobase pairs (kb) of 3' flanking sequence but no protein coding sequences (24 shown). CAT activity from male and female heterozygous offspring of each founder showed roughly similar patterns of expression with modest and uneven expression of the transgene in brain ( Fig. 1 ) and peripheral tissues ( Fig. 2) including spleen, ovary, small intestine, adrenal, and liver. Expression in testis was high in males tested from each line.
Brain CAT activity exceeded background values in striatum, brainstem, hippocampus, cervical spinal cord, and cerebral cortex (P < 0.05 in each case). Highest activity was found in the hippocampus and cervical cord (Fig. 1) . The patterns ofregional expression were similar in each ofthe five lines. Lines HEC1, HEC3, and HEC5 are described in detail, and line HEC5 was examined for studies of synaptic regulation with confirmatory experiments carried out in HEC2 animals (data not shown).
Northern analyses of RNA extracted from line HEC5 revealed high testis expression of an mRNA of 1.5 kb (arrow, Fig. 3 ) that hybridized with the random-primed cDNA directed against CAT. An identically sized mRNA, seen in both cortex and testis mRNA, hybridized with the oligonucleotide complementary to the 5' end of human preproenkephalin mRNA, indicating that transcriptional initiation is unlikely to be 3' to its normal start site (data not shown).
Animals were treated for 3 days with haloperidol, a classic upregulator of preproenkephalin (45) . Treated HEC5 mice showed 4-to 6-fold increases in striatal CAT activity (P c 0.005; Fig. 4 ), marginally significant increases in cerebral cortex (nucleus accumbens included) specimens, and unchanged CAT activity in the other brain regions (Fig. 4) or peripheral tissues (data not shown). increase in CAT activity that paralleled findings for the endogenous gene (5, 6) . These studies revealed a 4-to 7-fold enhancement in CAT activity ipsilateral to the adjuvant injection (P c 0.025; Fig. 5 ).
In mice sacrificed 2 hr after PTZ-induced seizures, no significant changes in CAT activity were detected in three experiments (Fig. 6 Upper). RNA extracted from BSJL6 wild-type mice subjected to identical seizures and sacrificed at the same time points did show significantly (-2-fold) enhanced expression of the endogenous preproenkephalin gene (Fig. 6 Lower), detected by a radiolabeled rat preproenkephalin cDNA (46) in Northern analyses normalized for loading by washing and reprobing with radiolabeled human ,3-actin cDNA (47) .
DISCUSSION
The present work documents the patterns of expression conferred by a cassette-region construct of the preproenkephalin gene promoter and the regulation that these sequences can mediate.
Parallels with wild-type gene expression are consistent with necessary and sufficient roles for the sequences studied here in some aspects of gene regulation. The brain, testis, (48) . Several central nervous system regions that display significant preproenkephalin mRNA levels also display CAT activity above background levels in HEC mice, including cerebral cortex, hippocampus, and striatum (48) . These findings provide some contrast to work in cultured cells (49) and highlight the importance of using transgenic mice for analysis of regulatory elements conferring tissue specificity.
Two of the three studied examples of preproenkephalin synaptic regulation show striking similarities with the regulation of the wild-type gene. The upregulation of preproenkephalin mRNA in striatum after treatment with haloperidol (21, 23, 44, 50, 51) accords nicely with our findings of 4-to 6-fold CAT upregulation induced by the same drug. The regional distribution of this effect, largely limited to the striatum, again fits well with the fact that the wild-type gene is upregulated by dopaminergic agents in striatum and accumbens only (45, 50) . Drugs that influence striatal dopaminergic function can alter several of the transcription factors that could interact with the preproenkephalin promoter cassette (52) . These results suggest that the gene regions studied here, while insufficient for full basal striatal expression, are nevertheless sufficient for prominent preproenkephalin upregulation upon dopamine receptor blockade.
Primary afferent stimulation provides trans-synaptic regulation in the spinal cord. Injection of adjuvant into the footpad induces an inflammatory response that is likely to stimulate both large-and small-fiber inputs to dorsal horn enkephalinergic neurons, where preproenkephalin expression is enhanced 1.5-to 2-fold (6). The 4-to 7-fold enhancement of CAT activity observed in the present study suggests that the promoter/enhancer regions studied here suffice to yield upregulation. Primary afferent stimulation has also been noted to upregulate dorsal horn expression of a number of transcription factors with possible activities at this promoter region (31) (32) (33) 53) .
The finding of similar patterns of expression in several lines of mice incorporating the preproenkephalin promoter/CAT construct (HEC) suggests that regions within this construct are responsible for the patterns of expression noted. Each line of HEC transgenic animals shares patterns of expression that are similar to one another but different from the wildtype gene. One striking difference lies in the level of expression. Northern blot comparison of levels of the mRNAs encoding the transgene and the endogenous preproenkephalin gene demonstrates that the sequences used here allow transgene expression at levels comparable to those of the wild-type gene only in testis (data not shown). CAT assays also indicate that HEC animals robustly express this gene construct only in testis, while brain levels of expression are a small fraction of testis values. The wild-type gene, on the other hand, is expressed at roughly similar levels in brain and testis (54) . That high-level testis expression is conferred in all HEC lines suggests that this level of expression is dependent on the specific sequences in the preproenkephalin promoter cassette or associated regions and not on the site of insertion of the transgene into the mouse genome. Although we have focused on the well-studied cassette sequences in the. 5 Differences from wild-type gene expression imply that the promoter cassette sequences are insufficient to confer all of the expression patterns characteristic of the wild-type gene, although they could still prove necessary in combination with other elements missing from the constructs. Brain region-toregion differences in CAT activity display significant differences from preproenkephalin expression. Striatum displays CAT levels no higher than those of the hippocampus, despite striatal preproenkephalin mRNA levels as much as 6-12 times those in hippocampus (48) . Both the differences in regional rank order of expression and the absolutely lower levels of expression in brain as a whole, when compared to expression of the endogenous gene, argue that additional regulatory elements are necessary to achieve wild-type expression levels in nontesticular tissues. Additional regulatory elements could lie further 5' to the transcriptional start site. Achieving full wild-type expression levels and patterns could also require proper intron/exon structure (55) .
One major and well-documented example of synaptic regulation is absent from HEC mice. The upregulation of preproenkephalin mRNA levels in hippocampus following seizures has been extensively studied in several laboratories (9, 12, 34) . Northern analyses (Fig. 6 ) document upregulation of the wild-type gene in the mouse strains used here. Each animal examined displayed a behaviorally unmistakable seizure. Nevertheless, CAT activities extracted from the hippocampi and striata of mice sacrificed after seizures in each of three experiments showed no significant differences from saline-injected control values. There appears to have been sufficient time for the modestly expressed transgene to significantly accumulate product; recent experiments using electrical peripheral nerve stimulation in HEC5 mice have documented 1.5-to 2-fold increases in dorsal horn CAT activity in the nucleus caudalis in animals sacrificed well within 2 hr of treatment onset (56) . Although transcription factors that recognize sequences in the preproenkephalin promoter cassette region are upregulated in hippocampus following seizures, the HEC construct appears to be insufficient to recognize all of the intracellular mediators required for seizure-induced preproenkephalin upregulation.
A number of studies in transgenic animals have characterized the ability of specific regulatory sequences, usually those found in 5' flanking regions, to confer cell type-, development-and tissue-specific expression (57, 58) . Fewer studies have examined the ability of specific promoter regions to confer in vivo regulation with hormonal activity changes (37) . Little work documents which gene regulatory elements are necessary for synaptic and trans-synaptic gene regulation in neurons in vivo. Synaptic regulation in each circuit does not appear to utilize the same constellation of DNA-binding domains. Study of regulatory processes in specific neurons within specific circuits is thus crucial for full understanding of mechanisms of synaptic gene regulation in the brain. 
